Ceri H. Davies - Publications

GlaxoSmithKline, Collegeville, PA, United States 

89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Williams LA, Joshi V, Murphy M, Ferrante J, Werley CA, Brookings T, McManus O, Grosse J, Davies CH, Dempsey GT. Scalable Measurements of Intrinsic Excitability in Human iPS Cell-Derived Excitatory Neurons Using All-Optical Electrophysiology. Neurochemical Research. PMID 30603979 DOI: 10.1007/S11064-018-2694-5  0.317
2017 Serrats J, Cunningham MO, Davies CH. GABAB receptor modulation-to B or not to be B a pro-cognitive medicine? Current Opinion in Pharmacology. PMID 29050820 DOI: 10.1016/J.Coph.2017.09.012  0.485
2013 Carracedo LM, Kjeldsen H, Cunnington L, Jenkins A, Schofield I, Cunningham MO, Davies CH, Traub RD, Whittington MA. A neocortical delta rhythm facilitates reciprocal interlaminar interactions via nested theta rhythms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 10750-61. PMID 23804097 DOI: 10.1523/Jneurosci.0735-13.2013  0.355
2013 Nathan PJ, Watson J, Lund J, Davies CH, Peters G, Dodds CM, Swirski B, Lawrence P, Bentley GD, O'Neill BV, Robertson J, Watson S, Jones GA, Maruff P, Croft RJ, et al. The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 721-31. PMID 22932339 DOI: 10.1017/S1461145712000752  0.329
2012 Gigout S, Jones GA, Wierschke S, Davies CH, Watson JM, Deisz RA. Distinct muscarinic acetylcholine receptor subtypes mediate pre- and postsynaptic effects in rat neocortex. Bmc Neuroscience. 13: 42. PMID 22540185 DOI: 10.1186/1471-2202-13-42  0.441
2012 Bashir ZI, Berretta N, Bortolotto ZA, Clark K, Davies CH, Frenguelli BG, Harvey J, Potier B, Collingridge GL. NMDA receptors and long-term potentiation in the hippocampus The Nmda Receptor. DOI: 10.1093/acprof:oso/9780192625021.003.0013  0.803
2011 Nathan PJ, Cobb SR, Lu B, Bullmore ET, Davies CH. Studying synaptic plasticity in the human brain and opportunities for drug discovery. Current Opinion in Pharmacology. 11: 540-8. PMID 21737346 DOI: 10.1016/J.Coph.2011.06.008  0.387
2011 Otton HJ, Lawson McLean A, Pannozzo MA, Davies CH, Wyllie DJ. Quantification of the Mg2+-induced potency shift of amantadine and memantine voltage-dependent block in human recombinant GluN1/GluN2A NMDARs. Neuropharmacology. 60: 388-96. PMID 20955720 DOI: 10.1016/J.Neuropharm.2010.10.008  0.35
2010 Spencer JP, Middleton LJ, Davies CH. Investigation into the efficacy of the acetylcholinesterase inhibitor, donepezil, and novel procognitive agents to induce gamma oscillations in rat hippocampal slices. Neuropharmacology. 59: 437-43. PMID 20600173 DOI: 10.1016/J.Neuropharm.2010.06.005  0.38
2010 Thomas DR, Dada A, Jones GA, Deisz RA, Gigout S, Langmead CJ, Werry TD, Hendry N, Hagan JJ, Davies CH, Watson JM. N-desmethylclozapine (NDMC) is an antagonist at the human native muscarinic M(1) receptor. Neuropharmacology. 58: 1206-14. PMID 20206188 DOI: 10.1016/J.Neuropharm.2010.02.017  0.302
2010 Dawson LA, Langmead CJ, Dada A, Watson JM, Wu Z, de la Flor R, Jones GA, Cluderay JE, Southam E, Murkitt GS, Hill MD, Jones DN, Davies CH, Hagan JJ, Smith PW. In vitro and in vivo comparison of two non-peptide tachykinin NK3 receptor antagonists: Improvements in efficacy achieved through enhanced brain penetration or altered pharmacological characteristics. European Journal of Pharmacology. 627: 106-14. PMID 19879867 DOI: 10.1016/J.Ejphar.2009.10.054  0.417
2010 McLean SL, Harte MK, Marsh S, Jones GA, Davies C, Woolley ML, Neill JC. Time-Dependent Changes in Gamma Oscillations and Parvalbumin Immunoreactive Cell Density in the Ca2/3 Region of the Rat Hippocampus Following Sub-Chronic Phencyclidine Treatment Schizophrenia Research. 117: 486. DOI: 10.1016/J.Schres.2010.02.920  0.352
2009 Dickinson BA, Jo J, Seok H, Son GH, Whitcomb DJ, Davies CH, Sheng M, Collingridge GL, Cho K. A novel mechanism of hippocampal LTD involving muscarinic receptor-triggered interactions between AMPARs, GRIP and liprin-alpha. Molecular Brain. 2: 18. PMID 19534762 DOI: 10.1186/1756-6606-2-18  0.708
2008 Piccinin S, Thuault SJ, Doherty AJ, Brown JT, Randall AD, Davies CH, Bortolotto ZA, Collingridge GL. The induction of long-term plasticity of non-synaptic, synchronized activity by the activation of group I mGluRs. Neuropharmacology. 55: 459-63. PMID 18619627 DOI: 10.1016/J.Neuropharm.2008.05.017  0.795
2008 Langmead CJ, Austin NE, Branch CL, Brown JT, Buchanan KA, Davies CH, Forbes IT, Fry VA, Hagan JJ, Herdon HJ, Jones GA, Jeggo R, Kew JN, Mazzali A, Melarange R, et al. Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1. British Journal of Pharmacology. 154: 1104-15. PMID 18454168 DOI: 10.1038/Bjp.2008.152  0.722
2008 Salah-Uddin H, Thomas DR, Davies CH, Hagan JJ, Wood MD, Watson JM, Challiss RA. Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue. The Journal of Pharmacology and Experimental Therapeutics. 325: 869-74. PMID 18322150 DOI: 10.1124/Jpet.108.137968  0.34
2008 Dawson LA, Cato KJ, Scott C, Watson JM, Wood MD, Foxton R, de la Flor R, Jones GA, Kew JN, Cluderay JE, Southam E, Murkitt GS, Gartlon J, Pemberton DJ, Jones DN, ... Davies CH, et al. In vitro and in vivo characterization of the non-peptide NK3 receptor antagonist SB-223412 (talnetant): potential therapeutic utility in the treatment of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1642-52. PMID 17728699 DOI: 10.1038/Sj.Npp.1301549  0.42
2007 Driver JE, Racca C, Cunningham MO, Towers SK, Davies CH, Whittington MA, LeBeau FE. Impairment of hippocampal gamma-frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP). The European Journal of Neuroscience. 26: 1280-8. PMID 17767505 DOI: 10.1111/J.1460-9568.2007.05705.X  0.345
2007 Brown JT, Davies CH, Randall AD. Synaptic activation of GABA(B) receptors regulates neuronal network activity and entrainment. The European Journal of Neuroscience. 25: 2982-90. PMID 17561812 DOI: 10.1111/J.1460-9568.2007.05544.X  0.794
2007 Bibbig A, Middleton S, Racca C, Gillies MJ, Garner H, Lebeau FE, Davies CH, Whittington MA. Beta rhythms (15-20 Hz) generated by nonreciprocal communication in hippocampus. Journal of Neurophysiology. 97: 2812-23. PMID 17287437 DOI: 10.1152/Jn.01105.2006  0.325
2007 McNair K, Broad J, Riedel G, Davies CH, Cobb SR. Global changes in the hippocampal proteome following exposure to an enriched environment. Neuroscience. 145: 413-22. PMID 17261355 DOI: 10.1016/J.Neuroscience.2006.12.033  0.317
2006 Wood MD, Scott C, Clarke K, Westaway J, Davies CH, Reavill C, Hill M, Rourke C, Newson M, Jones DN, Forbes IT, Gribble A. Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties. European Journal of Pharmacology. 546: 88-94. PMID 16925992 DOI: 10.1016/J.Ejphar.2006.07.008  0.354
2006 Wood MD, Scott C, Clarke K, Cato KJ, Patel N, Heath J, Worby A, Gordon L, Campbell L, Riley G, Davies CH, Gribble A, Jones DN. Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade. Cns & Neurological Disorders Drug Targets. 5: 445-52. PMID 16918396 DOI: 10.2174/187152706777950693  0.362
2006 Thomas DR, Soffin EM, Roberts C, Kew JN, de la Flor RM, Dawson LA, Fry VA, Coggon SA, Faedo S, Hayes PD, Corbett DF, Davies CH, Hagan JJ. SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain. Neuropharmacology. 51: 566-77. PMID 16846620 DOI: 10.1016/J.Neuropharm.2006.04.019  0.358
2006 Widmer H, Ferrigan L, Davies CH, Cobb SR. Evoked slow muscarinic acetylcholinergic synaptic potentials in rat hippocampal interneurons. Hippocampus. 16: 617-28. PMID 16770798 DOI: 10.1002/Hipo.20191  0.493
2006 Cunningham MO, Pervouchine DD, Racca C, Kopell NJ, Davies CH, Jones RS, Traub RD, Whittington MA. Neuronal metabolism governs cortical network response state. Proceedings of the National Academy of Sciences of the United States of America. 103: 5597-601. PMID 16565217 DOI: 10.1073/Pnas.0600604103  0.312
2006 Cunningham MO, Hunt J, Middleton S, LeBeau FE, Gillies MJ, Gillies MG, Davies CH, Maycox PR, Whittington MA, Racca C. Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2767-76. PMID 16525056 DOI: 10.1523/Jneurosci.5054-05.2006  0.481
2006 Gill CH, Brown JT, Shivji N, Lappin SC, Farmer C, Randall A, McNaughton NC, Cobb SR, Davies CH. Inhibition of Ih reduces epileptiform activity in rodent hippocampal slices. Synapse (New York, N.Y.). 59: 308-16. PMID 16421904 DOI: 10.1002/Syn.20242  0.757
2006 McNair K, Davies CH, Cobb SR. Plasticity-related regulation of the hippocampal proteome. The European Journal of Neuroscience. 23: 575-80. PMID 16420465 DOI: 10.1111/J.1460-9568.2005.04542.X  0.507
2005 Lappin SC, Dale TJ, Brown JT, Trezise DJ, Davies CH. Activation of SK channels inhibits epileptiform bursting in hippocampal CA3 neurons. Brain Research. 1065: 37-46. PMID 16336949 DOI: 10.1016/J.Brainres.2005.10.024  0.697
2005 Thuault SJ, Brown JT, Calver AR, Collingridge GL, Randall A, Davies CH. Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices expressing a C-terminal truncated GABA(B2) receptor subunit. Epilepsy Research. 65: 41-51. PMID 15979855 DOI: 10.1016/J.Eplepsyres.2005.04.004  0.803
2005 Cobb SR, Davies CH. Cholinergic modulation of hippocampal cells and circuits. The Journal of Physiology. 562: 81-8. PMID 15528238 DOI: 10.1113/Jphysiol.2004.076539  0.478
2005 Brown JT, Richardson JC, Collingridge GL, Randall AD, Davies CH. Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice. Hippocampus. 15: 110-7. PMID 15390159 DOI: 10.1002/Hipo.20036  0.835
2004 Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies CH. Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology. 46: 1168-1176. PMID 32585789 DOI: 10.1016/j.neuropharm.2004.02.014  0.311
2004 Thuault SJ, Brown JT, Sheardown SA, Jourdain S, Fairfax B, Spencer JP, Restituito S, Nation JH, Topps S, Medhurst AD, Randall AD, Couve A, Moss SJ, Collingridge GL, Pangalos MN, ... Davies CH, et al. The GABA(B2) subunit is critical for the trafficking and function of native GABA(B) receptors. Biochemical Pharmacology. 68: 1655-66. PMID 15451409 DOI: 10.1016/J.Bcp.2004.07.032  0.763
2004 Gill CH, Randall A, Bates SA, Hill K, Owen D, Larkman PM, Cairns W, Yusaf SP, Murdock PR, Strijbos PJ, Powell AJ, Benham CD, Davies CH. Characterization of the human HCN1 channel and its inhibition by capsazepine. British Journal of Pharmacology. 143: 411-21. PMID 15351778 DOI: 10.1038/Sj.Bjp.0705945  0.544
2004 Cunningham MO, Halliday DM, Davies CH, Traub RD, Buhl EH, Whittington MA. Coexistence of gamma and high-frequency oscillations in rat medial entorhinal cortex in vitro. The Journal of Physiology. 559: 347-53. PMID 15254156 DOI: 10.1113/Jphysiol.2004.068973  0.315
2004 McNaughton NC, Davies CH, Randall A. Inhibition of alpha(1E) Ca(2+) channels by carbonic anhydrase inhibitors. Journal of Pharmacological Sciences. 95: 240-7. PMID 15215649 DOI: 10.1254/Jphs.Fp0040032  0.495
2004 Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies CH. Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology. 46: 1168-76. PMID 15111023 DOI: 10.1016/J.Neuropharm.2004.02.014  0.424
2004 Gunthorpe MJ, Rami HK, Jerman JC, Smart D, Gill CH, Soffin EM, Luis Hannan S, Lappin SC, Egerton J, Smith GD, Worby A, Howett L, Owen D, Nasir S, Davies CH, et al. Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology. 46: 133-49. PMID 14654105 DOI: 10.1016/S0028-3908(03)00305-8  0.609
2004 Gunthorpe MJ, Rami HK, Jerman JC, Smart D, Gill CH, Soffin EM, Hannan SL, Lappin SC, Egerton J, Smith GD, Worby A, Howett L, Owen D, Nasir S, Davies CH, et al. Erratum to “Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist” [Neuropharmacology 46 (2004) 133–149] Neuropharmacology. 46: 905. DOI: 10.1016/J.Neuropharm.2004.01.016  0.391
2003 Brown JT, Gill CH, Farmer CE, Lanneau C, Randall AD, Pangalos MN, Collingridge GL, Davies CH. Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices of GABAB1 receptor subunit knockout mice. Epilepsy Research. 57: 121-36. PMID 15013053 DOI: 10.1016/J.Eplepsyres.2003.10.013  0.851
2003 Harrison SM, Reavill C, Brown G, Brown JT, Cluderay JE, Crook B, Davies CH, Dawson LA, Grau E, Heidbreder C, Hemmati P, Hervieu G, Howarth A, Hughes ZA, Hunter AJ, et al. LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease. Molecular and Cellular Neurosciences. 24: 1170-9. PMID 14697676 DOI: 10.1016/J.Mcn.2003.09.001  0.663
2003 Cunningham MO, Davies CH, Buhl EH, Kopell N, Whittington MA. Gamma oscillations induced by kainate receptor activation in the entorhinal cortex in vitro. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 9761-9. PMID 14586003 DOI: 10.1523/Jneurosci.23-30-09761.2003  0.407
2003 Charles KJ, Deuchars J, Davies CH, Pangalos MN. GABA B receptor subunit expression in glia. Molecular and Cellular Neurosciences. 24: 214-23. PMID 14550781 DOI: 10.1016/S1044-7431(03)00162-3  0.465
2003 Roshan-Milani S, Ferrigan L, Khoshnood MJ, Davies CH, Cobb SR. Regulation of epileptiform activity in hippocampus by nicotinic acetylcholine receptor activation. Epilepsy Research. 56: 51-65. PMID 14529953 DOI: 10.1016/J.Eplepsyres.2003.08.005  0.541
2003 van den Top M, Nolan MF, Lee K, Richardson PJ, Buijs RM, Davies CH, Spanswick D. Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. The Journal of Physiology. 549: 809-21. PMID 12702746 DOI: 10.1113/Jphysiol.2002.033290  0.352
2003 Cobb SR, Larkman PM, Bulters DO, Oliver L, Gill CH, Davies CH. Activation of Ih is necessary for patterning of mGluR and mAChR induced network activity in the hippocampal CA3 region. Neuropharmacology. 44: 293-303. PMID 12604089 DOI: 10.1016/S0028-3908(02)00405-7  0.489
2002 Calver AR, Davies CH, Pangalos M. GABA(B) receptors: from monogamy to promiscuity. Neuro-Signals. 11: 299-314. PMID 12566919 DOI: 10.1159/000068257  0.355
2002 Gillies MJ, Traub RD, LeBeau FE, Davies CH, Gloveli T, Buhl EH, Whittington MA. A model of atropine-resistant theta oscillations in rat hippocampal area CA1. The Journal of Physiology. 543: 779-93. PMID 12231638 DOI: 10.1113/Jphysiol.2002.024588  0.449
2002 Thuault SJ, Davies CH, Randall AD, Collingridge GL. Group I mGluRs modulate the pattern of non-synaptic epileptiform activity in the hippocampus. Neuropharmacology. 43: 141-6. PMID 12213268 DOI: 10.1016/S0028-3908(02)00095-3  0.818
2002 Lanneau C, Harries MH, Ray AM, Cobb SR, Randall A, Davies CH. Complex interactions between mGluR1 and mGluR5 shape neuronal network activity in the rat hippocampus. Neuropharmacology. 43: 131-40. PMID 12213267 DOI: 10.1016/S0028-3908(02)00086-2  0.655
2002 Coumis U, Davies CH. The effects of galanin on long-term synaptic plasticity in the CA1 area of rodent hippocampus. Neuroscience. 112: 173-82. PMID 12044482 DOI: 10.1016/S0306-4522(02)00007-6  0.416
2002 Soffin EM, Evans ML, Gill CH, Harries MH, Benham CD, Davies CH. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus. Neuropharmacology. 42: 127-33. PMID 11750922 DOI: 10.1016/S0028-3908(01)00156-3  0.436
2002 Gill CH, Soffin EM, Hagan JJ, Davies CH. 5-HT7 receptors modulate synchronized network activity in rat hippocampus. Neuropharmacology. 42: 82-92. PMID 11750918 DOI: 10.1016/S0028-3908(01)00149-6  0.472
2001 Lanneau C, Green A, Hirst WD, Wise A, Brown JT, Donnier E, Charles KJ, Wood M, Davies CH, Pangalos MN. Gabapentin is not a GABAB receptor agonist. Neuropharmacology. 41: 965-75. PMID 11747901 DOI: 10.1016/S0028-3908(01)00140-X  0.722
2001 Kearns IR, Morton RA, Bulters DO, Davies CH. Opioid receptor regulation of muscarinic acetylcholine receptor-mediated synaptic responses in the hippocampus. Neuropharmacology. 41: 565-73. PMID 11587711 DOI: 10.1016/S0028-3908(01)00108-3  0.565
2001 Morton RA, Manuel NA, Bulters DO, Cobb SR, Davies CH. Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by GABA(B) receptors in the rat hippocampus. The Journal of Physiology. 535: 757-66. PMID 11559773 DOI: 10.1111/J.1469-7793.2001.00757.X  0.541
2001 Davies B, Kearns IR, Ure J, Davies CH, Lathe R. Loss of hippocampal serine protease BSP1/neuropsin predisposes to global seizure activity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 6993-7000. PMID 11549709 DOI: 10.1523/Jneurosci.21-18-06993.2001  0.43
2001 Watson J, Roberts C, Scott C, Kendall I, Collin L, Day NC, Harries MH, Soffin E, Davies CH, Randall AD, Heightman T, Gaster L, Wyman P, Parker C, Price GW, et al. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue. British Journal of Pharmacology. 133: 797-806. PMID 11454652 DOI: 10.1038/Sj.Bjp.0704133  0.493
2001 Fitzjohn SM, Morton RA, Kuenzi F, Rosahl TW, Shearman M, Lewis H, Smith D, Reynolds DS, Davies CH, Collingridge GL, Seabrook GR. Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 4691-8. PMID 11425896 DOI: 10.1523/Jneurosci.21-13-04691.2001  0.793
2001 Prosser HM, Gill CH, Hirst WD, Grau E, Robbins M, Calver A, Soffin EM, Farmer CE, Lanneau C, Gray J, Schenck E, Warmerdam BS, Clapham C, Reavill C, Rogers DC, ... ... Davies CH, et al. Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice. Molecular and Cellular Neurosciences. 17: 1059-70. PMID 11414794 DOI: 10.1006/Mcne.2001.0995  0.598
2000 O'Meara G, Coumis U, Ma SY, Kehr J, Mahoney S, Bacon A, Allen SJ, Holmes F, Kahl U, Wang FH, Kearns IR, Ove-Ogren S, Dawbarn D, Mufson EJ, Davies C, et al. Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proceedings of the National Academy of Sciences of the United States of America. 97: 11569-74. PMID 11016971 DOI: 10.1073/Pnas.210254597  0.332
2000 Cobb SR, Bulters DO, Davies CH. Coincident activation of mGluRs and mAChRs imposes theta frequency patterning on synchronised network activity in the hippocampal CA3 region. Neuropharmacology. 39: 1933-42. PMID 10963737 DOI: 10.1016/S0028-3908(00)00036-8  0.448
2000 Fitzjohn SM, Morton RA, Kuenzi F, Davies CH, Seabrook GR, Collingridge GL. Similar levels of long-term potentiation in amyloid precursor protein -null and wild-type mice in the CA1 region of picrotoxin treated slices. Neuroscience Letters. 288: 9-12. PMID 10869803 DOI: 10.1016/S0304-3940(00)01204-0  0.792
1999 Cobb SR, Manuel NA, Morton RA, Gill CH, Collingridge GL, Davies CH. Regulation of depolarizing GABA(A) receptor-mediated synaptic potentials by synaptic activation of GABA(B) autoreceptors in the rat hippocampus. Neuropharmacology. 38: 1723-32. PMID 10587088 DOI: 10.1016/S0028-3908(99)00158-6  0.765
1999 Cobb SR, Bulters DO, Suchak S, Riedel G, Morris RG, Davies CH. Activation of nicotinic acetylcholine receptors patterns network activity in the rodent hippocampus. The Journal of Physiology. 518: 131-40. PMID 10373695 DOI: 10.1111/J.1469-7793.1999.0131R.X  0.44
1999 Pozza MF, Manuel NA, Steinmann M, Froestl W, Davies CH. Comparison of antagonist potencies at pre- and post-synaptic GABA(B) receptors at inhibitory synapses in the CA1 region of the rat hippocampus. British Journal of Pharmacology. 127: 211-9. PMID 10369475 DOI: 10.1038/Sj.Bjp.0702498  0.551
1999 Seabrook GR, Smith DW, Bowery BJ, Easter A, Reynolds T, Fitzjohn SM, Morton RA, Zheng H, Dawson GR, Sirinathsinghji DJ, Davies CH, Collingridge GL, Hill RG. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology. 38: 349-59. PMID 10219973 DOI: 10.1016/S0028-3908(98)00204-4  0.803
1998 Manuel NA, Davies CH. Pharmacological modulation of GABA(A) receptor-mediated postsynaptic potentials in the CA1 region of the rat hippocampus. British Journal of Pharmacology. 125: 1529-42. PMID 9884082 DOI: 10.1038/Sj.Bjp.0702237  0.499
1998 Steel M, Moss J, Clark KA, Kearns IR, Davies CH, Morris RG, Skarnes WC, Lathe R. Gene-trapping to identify and analyze genes expressed in the mouse hippocampus. Hippocampus. 8: 444-57. PMID 9825957 DOI: 10.1002/(Sici)1098-1063(1998)8:5<444::Aid-Hipo5>3.0.Co;2-X  0.452
1997 Clarke VR, Ballyk BA, Hoo KH, Mandelzys A, Pellizzari A, Bath CP, Thomas J, Sharpe EF, Davies CH, Ornstein PL, Schoepp DD, Kamboj RK, Collingridge GL, Lodge D, Bleakman D. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature. 389: 599-603. PMID 9335499 DOI: 10.1038/39315  0.725
1997 Morton RA, Davies CH. Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by adenosine receptors in the rat hippocampus. The Journal of Physiology. 502: 75-90. PMID 9234198 DOI: 10.1111/j.1469-7793.1997.075bl.x  0.47
1996 Davies CH, Collingridge GL. Regulation of EPSPs by the synaptic activation of GABAB autoreceptors in rat hippocampus. The Journal of Physiology. 496: 451-70. PMID 8910229 DOI: 10.1113/Jphysiol.1996.Sp021698  0.725
1995 Vignes M, Clarke VR, Davies CH, Chambers A, Jane DE, Watkins JC, Collingridge GL. Pharmacological evidence for an involvement of group II and group III mGluRs in the presynaptic regulation of excitatory synaptic responses in the CA1 region of rat hippocampal slices. Neuropharmacology. 34: 973-82. PMID 8532178 DOI: 10.1016/0028-3908(95)00093-L  0.675
1995 Davies CH, Clarke VR, Jane DE, Collingridge GL. Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones. British Journal of Pharmacology. 116: 1859-69. PMID 8528571 DOI: 10.1111/J.1476-5381.1995.Tb16674.X  0.705
1995 Bushell TJ, Jane DE, Tse HW, Watkins JC, Davies CH, Garthwaite J, Collingridge GL. Antagonism of the synaptic depressant actions of L-AP4 in the lateral perforant path by MAP4. Neuropharmacology. 34: 239-41. PMID 7617150 DOI: 10.1016/0028-3908(95)00012-U  0.767
1995 Bortolotto ZA, Bashir ZI, Davies CH, Taira T, Kaila K, Collingridge GL. Studies on the role of metabotropic glutamate receptors in long-term potentiation: some methodological considerations. Journal of Neuroscience Methods. 59: 19-24. PMID 7475246 DOI: 10.1016/0165-0270(94)00189-N  0.838
1995 Clark K, Davies C, Bashir Z, Bortolotto Z, Collingridge G. Roles of glutamate receptors in LTP in the hippocampus Pharmacological Research. 31: 153. DOI: 10.1016/1043-6618(95)86870-4  0.83
1994 Bortolotto ZA, Bashir ZI, Davies CH, Collingridge GL. A molecular switch activated by metabotropic glutamate receptors regulates induction of long-term potentiation. Nature. 368: 740-3. PMID 8152485 DOI: 10.1038/368740A0  0.841
1994 Conquet F, Bashir ZI, Davies CH, Daniel H, Ferraguti F, Bordi F, Franz-Bacon K, Reggiani A, Matarese V, Condé F. Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1. Nature. 372: 237-43. PMID 7969468 DOI: 10.1038/372237A0  0.714
1993 Bashir ZI, Bortolotto ZA, Davies CH, Berretta N, Irving AJ, Seal AJ, Henley JM, Jane DE, Watkins JC, Collingridge GL. Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature. 363: 347-50. PMID 8388549 DOI: 10.1038/363347A0  0.841
1993 Davies CH, Pozza MF, Collingridge GL. CGP 55845A: a potent antagonist of GABAB receptors in the CA1 region of rat hippocampus. Neuropharmacology. 32: 1071-3. PMID 8295715 DOI: 10.1016/0028-3908(93)90073-C  0.726
1993 Davies CH, Collingridge GL. The physiological regulation of synaptic inhibition by GABAB autoreceptors in rat hippocampus. The Journal of Physiology. 472: 245-65. PMID 8145143 DOI: 10.1113/Jphysiol.1993.Sp019945  0.714
1992 Collingridge GL, Randall AD, Davies CH, Alford S. The synaptic activation of NMDA receptors and Ca2+ signalling in neurons. Ciba Foundation Symposium. 164: 162-71; discussion 1. PMID 1327677  0.837
1991 Davies CH, Starkey SJ, Pozza MF, Collingridge GL. GABA autoreceptors regulate the induction of LTP. Nature. 349: 609-11. PMID 1847993 DOI: 10.1038/349609A0  0.784
1990 Davies CH, Davies SN, Collingridge GL. Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus. The Journal of Physiology. 424: 513-31. PMID 2167975 DOI: 10.1113/Jphysiol.1990.Sp018080  0.639
1990 Davies CH, Collingridge GL. A method for studying physiological functions of presynaptic GABA(B) receptors in the rat hippocampal slice Journal of Physiology. 425: 24P.  0.688
1990 Randall AD, Schofield JG, Davies CH, Collingridge GL. The baclofen depression of excitatory synaptic transmission in rat hippocampus in vitro can be reversed by 2-hydroxy-saclofen Journal of Physiology. 426: 51P.  0.329
Show low-probability matches.